|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
1991-4-9
|
|
pubmed:abstractText |
Oxidatively modified low-density lipoprotein is present in atherosclerotic lesions and has been proposed to play an important role in atherogenesis through its biologic effects on vascular cells. This study examined the effects of minimally oxidized preparations of LDL (MM-LDL) on tissue factor (TF) expression by cultured human endothelial cells. Low-density lipoprotein purified from normal donors was modified by exposure to iron or by prolonged storage, resulting in levels of thiobarbituric acid-reacting substances of approximately 2.5 to 4 nmoles/mg cholesterol. Preparations had less than 2.5 pg of endotoxin per microgram LDL and had no intrinsic procoagulant activity. This form of modified but not native LDL induced TF expression in endothelial cells in a time- and dose-dependent manner. Peak TF coagulant activity in cells exposed to 40 micrograms/ml MM-LDL were observed at 4 to 6 hours, and ranged from 50 to 500 pg/10(5) cells, compared with less than 10 pg/10(5) cells exposed to native LDL. Northern blot analysis showed TF mRNA levels to increase approximately 30-fold with exposure to MM-LDL for 2 hours. Induction of TF activity was dependent on the concentration of MM-LDL from 1 microgram/ml to 80 micrograms/ml, a range in which cell viability and morphology were unaffected. The findings suggest that minimally oxidized LDL may be a local mediator promoting thrombosis in atherosclerotic lesions.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/2000938-1690354,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2000938-1693617,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2000938-2300583,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2000938-2318980,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2000938-2440339,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2000938-2455346,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2000938-2462353,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2000938-2492262,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2000938-2555368,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2000938-2683796,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2000938-2704749,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2000938-2718149,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2000938-2719077,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2000938-2783195,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2000938-2794046,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2000938-3194899,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2000938-3275472,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2000938-3277885,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2000938-3279259,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2000938-3297348,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2000938-3319231,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2000938-3413716,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2000938-3478721,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2000938-3493488,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2000938-3536791,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2000938-3558489,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2000938-3571245,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2000938-487428,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2000938-6312838,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2000938-6774730,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2000938-6847521,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2000938-7240410,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2000938-7240413
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0002-9440
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
138
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
601-7
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:2000938-Blood Coagulation,
pubmed-meshheading:2000938-Blotting, Northern,
pubmed-meshheading:2000938-Cells, Cultured,
pubmed-meshheading:2000938-Dose-Response Relationship, Drug,
pubmed-meshheading:2000938-Endothelium, Vascular,
pubmed-meshheading:2000938-Humans,
pubmed-meshheading:2000938-Lipoproteins, LDL,
pubmed-meshheading:2000938-Oxidation-Reduction,
pubmed-meshheading:2000938-RNA, Messenger,
pubmed-meshheading:2000938-Thromboplastin
|
|
pubmed:year |
1991
|
|
pubmed:articleTitle |
Minimally oxidized low-density lipoprotein induces tissue factor expression in cultured human endothelial cells.
|
|
pubmed:affiliation |
Department of Pathology and Laboratory Medicine, UCLA 90024-1732.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|
